Clinical Trial Update: NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for NGA-01 Gel in osteoarthritis with joint pain across Phase 2 and Phase 3 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• NGA-01 Gel

Snippet

Sponsor: Nutrin GmbH | Conditions: Arthritis Osteoarthritis | Phase 2, Phase 3 | Status: COMPLETED